Natco Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NATCO PHARMA, and what generic and branded alternatives to NATCO PHARMA drugs are available?
NATCO PHARMA has forty-eight approved drugs.
There are two tentative approvals on NATCO PHARMA drugs.
Summary for Natco Pharma
| US Patents: | 0 |
| Tradenames: | 44 |
| Ingredients: | 44 |
| NDAs: | 48 |
| Patent Litigation for Natco Pharma: | See patent lawsuits for Natco Pharma |
Drugs and US Patents for Natco Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 079142-002 | Aug 3, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Natco Pharma Ltd | ERLOTINIB HYDROCHLORIDE | erlotinib hydrochloride | TABLET;ORAL | 208488-002 | Nov 5, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Natco Pharma | OLANZAPINE | olanzapine | TABLET;ORAL | 076866-002 | Apr 23, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Natco Pharma Usa | FLUOXETINE HYDROCHLORIDE | fluoxetine hydrochloride | CAPSULE;ORAL | 078045-001 | Nov 17, 2008 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Natco Pharma | OLANZAPINE | olanzapine | TABLET;ORAL | 076866-001 | Apr 23, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
